Autoantibodies: New upstream targets of paroxysmal atrial fibrillation in patients with congestive heart failure

Journal of Cardiology

Volumn 40, Issue 5, 2002, Pages 217-223

  Baba, Akiyasu ^a   Yoshikawa, Tsutomu ^b   Chino, Masao ^c   Murayama, Akira ^d   Mitani, Kazuhiko ^e   Nakagawa, Susumu ^f   Fujii, Isao ^b   Shimada, Megumi ^a   Koyama, Takashi ^g   Akaishi, Makoto ^a   Mitamura, Hideo ^b   Ogawa, Satoshi ^b  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^d Saitama Municipal Hospital   (Japan)

^e NKK Hospital   (Japan)

^f SAISEIKAI CENTRAL HOSPITAL   (Japan)

^g Life Extension Research Institute   (Japan)

Author keywords

Antibodies (autoantibodies); Atrial fibrillation (paroxysmal); Cardiomyopathies, dilated; Heart failure

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATRIAL NATRIURETIC FACTOR; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME ANTIBODY; MYOSIN ANTIBODY; NORADRENALIN; POTASSIUM; RECEPTOR ANTIBODY; BETA 2 ADRENERGIC RECEPTOR; MYOSIN;

ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HOLTER MONITORING; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE ANALYSIS; NORADRENALIN BLOOD LEVEL; POTASSIUM BLOOD LEVEL; RISK FACTOR; SEX; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED;

ATRIAL FIBRILLATION; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOSINS; NA(+)-K(+)-EXCHANGING ATPASE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 17344391468     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Members of the Sicilian Gambit: The search for novel antiarrhythmic strategies: Sicilian Gambit. Jpn Circ J 1998; 62: 633-648
2. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN, for the Department of Veterans Affairs CHF-STAT Investigators: Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation 1998; 98: 2574-2579
3. Maixent JM, Paganelli F, Scaglione J, Levy S: Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 612-617
4. Baba A, Yoshikawa T, Chino M, Murayama A, Mitani K, Nakagawa S, Fujii I, Shimada M, Akaishi M, Iwanaga S, Asakura Y, Fukuda K, Mitamura H, Ogawa S, Keio Interhospital Cardiology Study (KICS) Group: Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. Jpn Circ J 2001; 65: 867-873
5. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842
6. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S: Autoantibodies against the second extracellular loop of beta 1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37: 418-424
7. Caforio AL, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ: Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777
8. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F: Autoantibodies activating human beta 1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999; 99: 649-654
9. Baba A, Yoshikawa T, Ogawa S: Autoantibodies produced against sarcolemmal Na-K-ATPase: Possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-1159
10. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A, for the College of French Cardiologists: Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. Circulation 1999; 99: 3028-3035
11. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C: Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-380
12. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K: Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-2617
13. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184
14. Ther Res 2001; 22: 443-446
15. Kawai S, Ih S, Koizumi K: Pathology of atrial fibrillation. J Cardiol 1999; 33(Suppl I): 47-52 (in Jpn with Eng abstr)
16. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ: Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001; 103: 1765-1771
17. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U: Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 2001; 33: 1515-1525